since the toxicity of pertussis vaccine is related in part to endotoxin , we suggest that a clinical study using a combination of the vaccine with an endotoxin-neutralizing agent be done to assess both amelioration of side effects caused by the vaccine and any effect on immunogenesis .
C0206253
combination
C0042210
vaccine